<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03717636</url>
  </required_header>
  <id_info>
    <org_study_id>PSInCor-ICxHospDia</org_study_id>
    <nct_id>NCT03717636</nct_id>
  </id_info>
  <brief_title>Early or Non-revoked in Hospital-day in Patients With Acute Heart Failure</brief_title>
  <acronym>HospDia</acronym>
  <official_title>Prospective and Randomized Comparative Analysis, Between Early or Non-revoked in Day Hospital in Patients With Acute Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure is one of the major causes of hospitalization in Brazil and worldwide. Recent
      studies attempt to identify readmission and prognostic markers at the time of discharge from
      these patients. The reassessment and possibility of early therapeutic adjustment may be
      relevant in this context. Therefore, the prospective and randomized comparative use of early
      re-evaluation in Hospital-day versus non-intervention group has not yet been described. The
      objective of this study was to evaluate the impact on the re-hospitalization rate in 30 days
      of the early re-evaluation of the patients in the day-hospital versus the non-intervention
      group in heart failure. For this, a unicentric, randomized and prospective study will be
      performed, in which the Hospital-Day strategy is performed versus no intervention in a
      comparative manner. Hospital data (test results, medical outcomes, complications) of patients
      will be analyzed for safety and effectiveness. The hypothesis of this study is that the
      Hospital-Day strategy is superior to the non-intervention strategy and causes fewer
      rehospitalizations within 30 days.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of 30-days rehospitalization rate</measure>
    <time_frame>30 days</time_frame>
    <description>30-days rehospitalization rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>30-days mortality rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Heart Failure</condition>
  <condition>Acute Heart Failure</condition>
  <arm_group>
    <arm_group_label>Hospital Day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the Hospital-Day group will return for medical evaluation 7-14 days in the specific unit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Outpatient clinic</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patients in control group will return for medical evaluation 30 days at the outpatient clinic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical evaluation</intervention_name>
    <description>return of medical evaluation after discharge</description>
    <arm_group_label>Hospital Day</arm_group_label>
    <arm_group_label>Outpatient clinic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult men and women aged&gt; 18 years.

          -  Presence of decomposed CF III or IV of NYHA characterized by&gt; 1 symptom (dyspnea,
             orthopnea or edema) + 1 clinical sign (rales, edema, ascites or pulmonary congestion
             on chest X-ray).

          -  LVEF &lt;45% on transthoracic echocardiography.

          -  BNP&gt; 400 pg / mL.

          -  Clinical condition of hospital discharge.

          -  Signed consent form.

        Exclusion Criteria:

          -  Pregnancy

          -  Body mass index greater than 40 kg / m2.

          -  Chronic obstructive pulmonary disease.

          -  Acute coronary syndrome.

          -  Acute myocarditis.

          -  Valvular heart disease.

          -  Need to use vasoactive drug.

          -  Cirrhosis of the liver Child C.

          -  Chronic dialysis renal insufficiency or creatinine&gt; 3.0 mg / dL.

          -  Indication of implantation device of artificial stimulation.

          -  Pulmonary thromboembolism.

          -  Neoplasm terminal.

          -  Sepsis or septic shock.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mucio Tavares, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unidade Clínica de Emergência</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre Soeiro, MD</last_name>
    <phone>+55112661-5299</phone>
    <email>alexandre.soeiro@bol.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto do Coração - HMFMUSP</name>
      <address>
        <city>São Paulo</city>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandre Soeiro, MD</last_name>
      <phone>5511-2661-5299</phone>
      <email>alexandre.soeiro@bol.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 19, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2018</study_first_posted>
  <last_update_submitted>October 22, 2018</last_update_submitted>
  <last_update_submitted_qc>October 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

